1: (ROOT (S (NP (NP (NN Drug)) (VP (VBN Used) (PP (IN In) (NP (NNP Japan))) (S (VP (VBG Showing) (NP (NP (NNP Promise)) (PP (IN Against) (NP (NP (NNP COVI-19A) (NN drug)) (VP (VBN used) (PP (IN in) (NP (NNP Japan))) (S (VP (TO to) (VP (VB treat) (NP (NNP influenza))))))))))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG treating) (NP (HYPH COVI-19))))))))) (, ,) (PP (VBG according) (PP (IN to) (NP (NP (NNS reports)) (SBAR (S (NP (NNS doctors)) (VP (VBP have) (VP (VBN found) (NP (JJ clear) (NN evidence) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ improves) (NP (NN coronavirus) (NNS symptoms)))))))))))))) (. .)))
2: (ROOT (S (NP (NNP Favipiravi) (SYM /) (NNP Avigan)) (VP (VBZ is) (NP (NP (DT an) (NN antiviral)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBG showing) (NP (JJ positive) (NNS outcomes)) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (VP (VBG involving) (NP (NP (CD 340) (NNS patients)) (PP (IN in) (NP (NNP Wuhan) (CC and) (NNP Shenzhen))))))) (PP (VBG according) (PP (IN to) (NP (NP (DT a) (NN statement)) (VP (VBN made) (PP (IN by) (NP (NNP Zhang) (NNP Xinmin))) (PP (IN in) (NP (NP (DT a) (NN report)) (PP (IN in) (NP (DT The) (NNP Guardian)))))))))))))))) (. .) ('' ')))
3: (ROOT (S (S (NP (PRP It)) (VP (VP (VBZ has) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NN safety))))) (CC and) (VP (VBZ is) (ADJP (RB clearly) (JJ effective) (PP (IN in) (NP (NN treatment))))))) (, ,) ('' ') (NP (NNP Zhang)) (VP (VBD said)) (. .)))
4: (ROOT (S (S (NP (NNP Favipiravi) (SYM /) (NNP Avigan)) (VP (VP (VBD was) (VP (VBN developed) (PP (IN by) (NP (NNP Fujifilm) (NNP Toyama) (NNP Chemical))))) (CC and) (VP (VBZ is) (VP (VBG being) (VP (VBN manufactured) (PP (IN by) (NP (NNP Zhejiang) (NNP Hisun) (NNP Pharmaceutical)))))))) (: ;) (CC and) (S (NP (PRP it)) (ADVP (RB recently)) (VP (VBD received) (NP (NP (NN approval)) (PP (IN as) (NP (NP (DT an) (JJ experimental) (NN treatment)) (PP (IN for) (NP (CD COVI-19) (NNS infections)))))) (, ,) (PP (VBG according) (PP (IN to) (NP (NNP Pharmaceutical) (NNP Technology)))))) (. .)))
5: (ROOT (NP (NP (NNP Shenzhen) (NNS patients)) (ADJP (ADJP (JJ positive) (PP (IN for) (NP (CD COIV-19)))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN given) (NP (NP (DT the) (NN drug)) (VBN tested) (ADJP (JJ negative))) (PP (NP (QP (RB only) (CD 4)) (NNS days)) (IN after) (NP (NN administration)))))))) (, ,) (PP (IN as) (PP (VBN compared) (PP (IN to) (NP (NP (DT a) (JJ negative) (NN test)) (ADVP (NP (CD 11) (NNS days)) (RB later)) (PP (IN for) (NP (NP (DT those)) (PP (IN with) (NP (DT no) (NN drug) (NN treatment))))))))) (. .)))
6: (ROOT (S (ADVP (RB Additionally)) (, ,) (NP (NP (NN lung) (NNS conditions)) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NNS -rays))))))) (VP (VBD improved) (PP (IN in) (NP (NP (CD 91) (NN %)) (PP (IN of) (NP (NP (DT those)) (VP (VBG taking) (NP (DT the) (NN drug))))))) (PP (IN as) (PP (VBN compared) (PP (IN to) (NP (NP (CD 61) (NN %)) (PP (IN of) (NP (NP (DT those)) (VP (RB not) (VBG taking) (NP (DT the) (NN drug)))))))))) (. .)))
7: (ROOT (S (SBAR (IN While) (S (ADJP (RB not) (RB as) (JJ effective)) (PP (IN in) (NP (NP (DT those)) (PP (IN with) (NP (JJ severe) (NNS symptoms))))))) (, ,) (PP (VBG according) (PP (IN to) (NP (NNP Pharmaceutical) (NNP Technology)))) (, ,) (NP (NNP Wuhan) (NNS patients)) (ADVP (RB also)) (VP (VBP have) (VP (VBN had) (NP (NP (JJ positive) (NNS results)) (PP (IN in) (NP (NP (NN shortening)) (PP (IN of) (NP (NN duration))) (PP (IN with) (NP (NP (NN fever) (NN reduction)) (PP (IN from) (NP (DT an) (JJ average) (CD .2) (NNS days))) (PP (IN to) (NP (CD .5) (NNS days)))))))))) (. .)))
8: (ROOT (S (`` `) (S (S (NP (PRP We)) (VP (VBP 've) (VP (VBN given) (NP (NNP Avigan)) (PP (IN to) (NP (QP (CD 70) (IN to) (CD 80)) (NNS people)))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ does) (`` ') (RB t) (VP (VB seem) (S (VP (TO to) (VP (VB work) (ADVP (RB that) (RB well)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN virus)) (VP (VBZ has) (ADVP (RB already)) (VP (VBN multiplied)))))))))))) (, ,) ('' ') (NP (NP (DT a) (NN source)) (PP (IN from) (NP (DT the) (JJ Japanese) (NNP Health) (NNP Ministry)))) (VP (VBD told) (NP (DT the) (NML (NNP Mainichi) (NNP Shimbun)) (NN newspaper)) (, ,) (PP (VBG according) (PP (IN to) (NP (DT The) (NNP Guardian))))) (. .)))
9: (ROOT (S (NP (NNP Favipiravi) (SYM /) (NNP Avigan)) (VP (VBZ is) (VP (VBN made) (S (VP (TO to) (VP (VB treat) (NP (NP (NP (NN RNA) (NNS viruses)) (PP (JJ such) (IN as) (NP (NNP SAR) (HYPH -) (CD Co-2)))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (NNS viruses)) (PP (IN with) (NP (NP (DT the) (JJ main) (JJ genetic) (NN material)) (PP (IN of) (NP (NP (NN RNA)) (PP (RB rather) (IN than) (NP (NNP DNA)))))))))))) (, ,) (PP (IN by) (S (VP (VBG stopping) (NP (NN replication)) (PP (IN via) (NP (NP (VBG crippling) (NML (NN RNA) (NN polymerase)) (NNS enzymes)) (SBAR (WHNP (WDT that)) (S (VP (VBP build) (NP (NN RNA))))))))))))))) (. .)))
10: (ROOT (S (PP (IN Without) (S (NP (DT the) (NN enzyme)) (VP (VBG being) (VP (VB entact))))) (NP (DT the) (NN virus)) (VP (VBZ is) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB duplicate) (NP (PRP$ its) (JJ genetic) (NNS materials)) (ADVP (RB once)) (PP (IN inside) (NP (DT a) (NN host) (NN cell))))))) (, ,) (PP (VBG according) (PP (IN to) (NP (NP (DT the) (NN drug) (NN description)) (VP (VBN published) (PP (IN in) (NP (NP (NP (DT the) (NN journal)) (NP (NNPS Proceedings))) (PP (IN of) (NP (NP (DT the) (NNP Japan) (NNP Academy)) (, ,) (NP (NNP Ser))))))))))) (. .)))
11: (ROOT (NP (NP (NNP B)) (, ,) (NP (ADJP (JJ Physical) (CC and) (JJ Biological)) (NNPS Sciences)) (. .)))
12: (ROOT (S (S (NP (DT The) (NNP Guardian)) (VP (VBZ reports) (SBAR (IN that) (S (NP (DT this) (NN drug)) (VP (VBZ is) (VP (VBG being) (VP (VBN used) (PP (IN in) (NP (NNP Japan))) (S (VP (TO to) (VP (VB treat) (NP (NP (DT those)) (PP (IN with) (NP (ADJP (JJ mild) (IN to) (JJ moderate)) (NNS symptoms)))) (PP (IN with) (NP (JJ positive) (NNS results))))))))))))) (, ,) (CC and) (S (NP (NP (JJ preliminary) (NNS findings)) (PP (IN of) (NP (DT these) (NNS trials)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN published) (PP (IN in) (NP (DT a) (ADJP (NN peer) (VBN reviewed)) (JJ scientific) (NN journal))) (PP (IN as) (PP (IN of) (ADVP (RB yet)))))))) (. .)))
13: (ROOT (S (NP (JJ Other) (NNS trials)) (VP (VBP have) (VP (VBN begun) (S (VP (TO to) (VP (VB test) (NP (NP (JJ other) (NNS drugs)) (CC and) (NP (DT an) (JJ experimental) (NN vaccine))) (PP (IN in) (NP (NNS humans)))))))) (. .)))
14: (ROOT (S (NP (CD 45) (NNS participants)) (VP (VBP are) (VP (VBN expected) (S (VP (TO to) (VP (VB enroll) (PP (IN in) (NP (NP (DT a) (NN vaccine) (NN trial)) (PP (IN in) (NP (NNP Seattle))))) (PP (IN over) (NP (DT the) (JJ next) (CD 6) (NNS weeks))) (S (VP (TO to) (VP (VB test) (NP (NP (PRP$ its) (NN safety)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB trigger) (NP (NML (JJ immune) (NN system)) (NNS responses)) (S (VP (TO to) (VP (VB fight) (PRT (RP off)) (NP (DT the) (NN coronavirus)))))))))))))))))) (. .)))
15: (ROOT (S (SBAR (IN If) (S (NP (DT this) (NN trial)) (VP (VBZ goes) (ADVP (RB well))))) (NP (DT this)) (VP (MD will) (VP (VB be) (VP (VBN followed) (PRT (RP up)) (PP (IN with) (NP (NP (CD 2) (NML (JJ clinical) (NN trial)) (NNS phases)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB take) (NP (QP (IN up) (IN to) (CD 1) (SYM -) (NP (CD 18))) (NNS months))))))))))) (. .)))
